ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in

Jakob Benedict Seidelin1, Mehmet Coskun, Ben Vainer

  • 1Department of Gastroenterology, Medical Section 54 O3, Herlev Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark. jseidelin@dadlnet.dk

Journal of Molecular Medicine (Berlin, Germany)
|February 2, 2013
PubMed

Insights

Impaired Fas receptor apoptosis signaling in ulcerative colitis (UC) involves the MEK-ERK pathway, which upregulates cellular FLICE-inhibitory protein (c-FLIPS). This explains epithelial resistance to apoptosis during UC flares and may contribute to cancer development.

Area of Science:

  • Cell Biology
  • Immunology
  • Gastroenterology

Background:

  • Intestinal epithelial cell (IEC) death via Fas receptor signaling is impaired in active ulcerative colitis (UC).
  • This impairment may stem from activated cytoprotective pathways limiting inflammation-induced tissue injury.

Purpose of the Study:

  • To investigate the roles of nuclear factor (NF)-κB and mitogen-activated protein kinase (MAPK) pathways in modifying Fas-mediated apoptosis.
  • To determine if these pathways regulate the expression of cellular FLICE-inhibitory protein (c-FLIP), an inhibitor of Fas-mediated apoptosis.

Main Methods:

  • Analysis of phospho-ERK and c-FLIP expression in IECs from active UC patients and in vitro cytokine-stimulated IECs.
  • Investigating the effects of inhibiting NF-κB, JNK, p38, and ERK pathways on c-FLIP expression and apoptosis.
  • Utilizing MEK1 RNA silencing and pharmacologic inhibitors to target the ERK pathway.

Main Results:

  • Phospho-ERK and the short splice variant c-FLIPS (c-FLIPS) were upregulated in IECs from active UC patients.
  • Pro-inflammatory cytokines (TNF-α, IL-1β, IFN-γ) induced c-FLIP variants, with TNF-α specifically inducing c-FLIPS in primary IECs.
  • ERK pathway inhibition, but not NF-κB, JNK, or p38 inhibition, decreased c-FLIPS expression and restored Fas ligand and TNF-α-mediated apoptosis.

Conclusions:

  • The MEK-ERK pathway is a key regulator of IEC apoptosis during UC flares, inducing c-FLIPS expression.
  • This pathway contributes to the observed resistance to receptor-mediated epithelial apoptosis in active UC.
  • Upregulated c-FLIP may promote the proliferation of DNA-damaged IECs, potentially increasing cancer risk in UC patients.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...